Front Barnett Associates’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$11K Hold
25,400
﹤0.01% 112
2023
Q2
$9K Buy
25,400
+12,400
+95% +$10.6K ﹤0.01% 119
2023
Q1
$24K Hold
13,000
﹤0.01% 116
2022
Q4
$27K Hold
13,000
﹤0.01% 113
2022
Q3
$39K Buy
13,000
+1,000
+8% +$3.54K 0.01% 111
2022
Q2
$38K Buy
12,000
+1,000
+9% +$5.42K ﹤0.01% 112
2022
Q1
$71K Buy
+11,000
New +$99.5K 0.01% 114

Other funds holding HLTH

Front Barnett Associates's HLTH Position: Q3 2023 in Review

Front Barnett Associates held its Cue Health Inc. Common Stock (HLTH) position steady in Q3 2023 at 25,400 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #112.

Front Barnett Associates first reported a position in HLTH in Q1 2022 and has held it in 7 quarters since. The position peaked at $71K in Q1 2022. 72 funds tracked by Wall St. Rank hold HLTH as of Q3 2023.

  • Front Barnett Associates held 25,400 shares of Cue Health Inc. Common Stock worth $11K as of Q3 2023.
  • Front Barnett Associates left its Cue Health Inc. Common Stock share count unchanged in Q3 2023.
  • Cue Health Inc. Common Stock made up ﹤0.01% of Front Barnett Associates's portfolio in Q3 2023, its #112 holding.
  • Front Barnett Associates first reported a position in Cue Health Inc. Common Stock in Q1 2022 and has held it in 7 quarters since.
  • Front Barnett Associates's Cue Health Inc. Common Stock position peaked at $71K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q3 2023.

Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.